The present invention relates to a lozenge composition for controlled releaseofcannabinoids comprising; i) a master granule component comprising one or moresolid particles and one or more cannabinoids reversibly associated with theone ormore solid particles; and ii) an extragranular component blended with themastergranule component comprising one or more extragranular sugar alcohols.